Literature DB >> 20388796

Molecular mechanism of chemoresistance by astrocyte elevated gene-1.

Byoung Kwon Yoo1, Dong Chen, Zhao-Zhong Su, Rachel Gredler, Jinsang Yoo, Khalid Shah, Paul B Fisher, Devanand Sarkar.   

Abstract

Our recent findings show that astrocyte elevated gene-1 (AEG-1) is overexpressed in >90% of human hepatocellular carcinoma (HCC) samples, and AEG-1 plays a central role in regulating development and progression of HCC. In the present study, we elucidate a molecular mechanism of AEG-1-induced chemoresistance, an important characteristic of aggressive cancers. AEG-1 increases the expression of multidrug resistance gene 1 (MDR1) protein, resulting in increased efflux and decreased accumulation of doxorubicin, promoting doxorubicin resistance. Suppression of MDR1 by small interfering RNA or chemical reagents, or inhibition of AEG-1 or a combination of both genes, significantly increases in vitro sensitivity to doxorubicin. In nude mice xenograft studies, a lentivirus expressing AEG-1 short hairpin RNA, in combination with doxorubicin, profoundly inhibited growth of aggressive human HCC cells compared with either agent alone. We document that although AEG-1 does not affect MDR1 gene transcription, it facilitates association of MDR1 mRNA to polysomes, resulting in increased translation, and AEG-1 also inhibits ubiquitination and subsequent proteasome-mediated degradation of MDR1 protein. This study is the first documentation of a unique aspect of AEG-1 function (i.e., translational and posttranslational regulation of proteins). Inhibition of AEG-1 might provide a means of more effectively using chemotherapy to treat HCC, which displays inherent chemoresistance with aggressive pathology. (c) 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388796      PMCID: PMC2855753          DOI: 10.1158/0008-5472.CAN-09-4009

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

Review 1.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; A Rzhetsky; R Allikmets
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

Review 2.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI.

Authors:  B Raught; A C Gingras; S P Gygi; H Imataka; S Morino; A Gradi; R Aebersold; N Sonenberg
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

4.  Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response.

Authors:  I O Ng; C L Liu; S T Fan; M Ng
Journal:  Am J Clin Pathol       Date:  2000-03       Impact factor: 2.493

5.  Insulin fails to stimulate muscle protein synthesis in sepsis despite unimpaired signaling to 4E-BP1 and S6K1.

Authors:  T C Vary; L S Jefferson; S R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-11       Impact factor: 4.310

6.  Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection.

Authors:  A Kato; M Miyazaki; S Ambiru; H Yoshitomi; H Ito; K Nakagawa; H Shimizu; O Yokosuka; N Nakajima
Journal:  J Surg Oncol       Date:  2001-10       Impact factor: 3.454

7.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

Authors:  R T Poon; S T Fan; C M Lo; I O Ng; C L Liu; C M Lam; J Wong
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

8.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Authors:  Josep M Llovet; Maria Isabel Real; Xavier Montaña; Ramon Planas; Susana Coll; John Aponte; Carmen Ayuso; Margarita Sala; Jordi Muchart; Ricard Solà; Joan Rodés; Jordi Bruix
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

9.  Amino acid-induced stimulation of translation initiation in rat skeletal muscle.

Authors:  T C Vary; L S Jefferson; S R Kimball
Journal:  Am J Physiol       Date:  1999-12

Review 10.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

View more
  63 in total

Review 1.  AEG-1/MTDH/LYRIC in liver cancer.

Authors:  Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 2.  The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

Authors:  Evan K Noch; Kamel Khalili
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

3.  Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice.

Authors:  Jyoti Srivastava; Ayesha Siddiq; Rachel Gredler; Xue-Ning Shen; Devaraja Rajasekaran; Chadia L Robertson; Mark A Subler; Jolene J Windle; Catherine I Dumur; Nitai D Mukhopadhyay; Dawn Garcia; Zhao Lai; Yidong Chen; Uthra Balaji; Paul B Fisher; Devanand Sarkar
Journal:  Hepatology       Date:  2015-01-23       Impact factor: 17.425

4.  MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression.

Authors:  Yonghong Wang; Yujun Wei; Haibo Tong; Laizhao Chen; Yimin Fan; Yuchen Ji; Wenqing Jia; Dongkang Liu; Guihuai Wang
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

5.  Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).

Authors:  Jyoti Srivastava; Chadia L Robertson; Rachel Gredler; Ayesha Siddiq; Devaraja Rajasekaran; Maaged A Akiel; Luni Emdad; Valeria Mas; Nitai D Mukhopadhyay; Paul B Fisher; Devanand Sarkar
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

6.  Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.

Authors:  Ming-Liang You; Yi-Jun Chen; Qing-Yun Chong; Ming-Ming Wu; Vijay Pandey; Ru-Mei Chen; Liang Liu; Lan Ma; Zheng-Sheng Wu; Tao Zhu; Peter E Lobie
Journal:  Oncotarget       Date:  2017-06-13

7.  AEG-1 regulates retinoid X receptor and inhibits retinoid signaling.

Authors:  Jyoti Srivastava; Chadia L Robertson; Devaraja Rajasekaran; Rachel Gredler; Ayesha Siddiq; Luni Emdad; Nitai D Mukhopadhyay; Shobha Ghosh; Phillip B Hylemon; Gregorio Gil; Khalid Shah; Deepak Bhere; Mark A Subler; Jolene J Windle; Paul B Fisher; Devanand Sarkar
Journal:  Cancer Res       Date:  2014-08-15       Impact factor: 12.701

8.  Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs.

Authors:  Xiangbing Meng; Shujie Yang; Yuping Zhang; Xinjun Wang; Renee X Goodfellow; Yichen Jia; Kristina W Thiel; Henry D Reyes; Baoli Yang; Kimberly K Leslie
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

9.  A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH).

Authors:  Jyoti Srivastava; Chadia L Robertson; Kareem Ebeid; Mikhail Dozmorov; Devaraja Rajasekaran; Rachel Mendoza; Ayesha Siddiq; Maaged A Akiel; Nidhi Jariwala; Xue-Ning Shen; Jolene J Windle; Mark A Subler; Nitai D Mukhopadhyay; Shah Giashuddin; Shobha Ghosh; Zhao Lai; Yidong Chen; Paul B Fisher; Aliasger K Salem; Arun J Sanyal; Devanand Sarkar
Journal:  Hepatology       Date:  2017-06-30       Impact factor: 17.425

10.  LMNA knock-down affects differentiation and progression of human neuroblastoma cells.

Authors:  Giovanna Maresca; Manuela Natoli; Marta Nardella; Ivan Arisi; Daniela Trisciuoglio; Marianna Desideri; Rossella Brandi; Simona D'Aguanno; Maria Rita Nicotra; Mara D'Onofrio; Andrea Urbani; Pier Giorgio Natali; Donatella Del Bufalo; Armando Felsani; Igea D'Agnano
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.